We provide you with 20 years of free, institutional-grade data for MRNS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MRNS. Explore the full financial landscape of MRNS stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2024-03-05 | 1267813 | MRNS | 10-K | Url |
| 2023-11-07 | 1267813 | MRNS | 10-Q | Url |
| 2023-08-10 | 1267813 | MRNS | 10-Q | Url |
| 2023-05-11 | 1267813 | MRNS | 10-Q | Url |
| 2023-03-09 | 1267813 | MRNS | 10-K | Url |
| 2022-11-07 | 1267813 | MRNS | 10-Q | Url |
| 2022-08-11 | 1267813 | MRNS | 10-Q | Url |
| 2022-05-12 | 1267813 | MRNS | 10-Q | Url |
| 2022-03-24 | 1267813 | MRNS | 10-K | Url |
| 2021-11-09 | 1267813 | MRNS | 10-Q | Url |
| 2021-08-10 | 1267813 | MRNS | 10-Q | Url |
| 2021-05-17 | 1267813 | MRNS | 10-Q | Url |
| 2021-03-09 | 1267813 | MRNS | 10-K | Url |
| 2020-11-09 | 1267813 | MRNS | 10-Q | Url |
| 2020-08-06 | 1267813 | MRNS | 10-Q | Url |
| 2020-05-04 | 1267813 | MRNS | 10-Q | Url |
| 2020-03-16 | 1267813 | MRNS | 10-K | Url |
| 2019-11-06 | 1267813 | MRNS | 10-Q | Url |
| 2019-08-08 | 1267813 | MRNS | 10-Q | Url |
| 2019-05-01 | 1267813 | MRNS | 10-Q | Url |
| 2019-03-12 | 1267813 | MRNS | 10-K | Url |
| 2018-10-29 | 1267813 | MRNS | 10-Q | Url |
| 2018-08-03 | 1267813 | MRNS | 10-Q | Url |
| 2018-05-02 | 1267813 | MRNS | 10-Q | Url |
| 2018-03-07 | 1267813 | MRNS | 10-K | Url |
| 2017-10-31 | 1267813 | MRNS | 10-Q | Url |
| 2017-08-01 | 1267813 | MRNS | 10-Q | Url |
| 2017-05-01 | 1267813 | MRNS | 10-Q | Url |
| 2017-03-13 | 1267813 | MRNS | 10-K | Url |
| 2016-11-08 | 1267813 | MRNS | 10-Q | Url |
| 2016-08-09 | 1267813 | MRNS | 10-Q | Url |
| 2016-05-02 | 1267813 | MRNS | 10-Q | Url |
| 2016-03-07 | 1267813 | MRNS | 10-K | Url |
| 2015-10-29 | 1267813 | MRNS | 10-Q | Url |
| 2015-08-04 | 1267813 | MRNS | 10-Q | Url |
| 2015-05-14 | 1267813 | MRNS | 10-Q | Url |
| 2015-03-12 | 1267813 | MRNS | 10-K | Url |
| 2014-11-13 | 1267813 | MRNS | 10-Q | Url |
| 2014-09-12 | 1267813 | MRNS | 10-Q | Url |
| 2014-05-12 | 1267813 | MRNS | S-1 | Url |
Marinus Pharmaceuticals, Inc(NASDAQ:MRNS) 
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat rare seizure disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including i...
Website: http://www.marinuspharma.com
Founded: 2003
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MRNS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.